Gavin Hirst
Directeur Technique/Scientifique/R&D chez TURG POIN
Provenance du réseau au premier degré de Gavin Hirst
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
34
| Subsidiary | Pharmaceuticals: Major | 34 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Gavin Hirst via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Founder Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member President | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Sales & Marketing | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of California, Irvine | College/University | Doctorate Degree Masters Business Admin | |
| OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| San Diego State University | College/University | Undergraduate Degree Graduate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Founder | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director of Finance/CFO | |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Packaged Software | Chairman Chief Executive Officer | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member President | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Chief Operating Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
Personal Genome Diagnostics, Inc.
 Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Biotechnology | Director/Board Member | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Packard Children's Health Alliance
 Packard Children's Health Alliance Hospital/Nursing ManagementHealth Services Packard Children's Health Alliance operates a medical and surgical hospital for children. The private company is based in Palo Alto, CA. | Hospital/Nursing Management | Director/Board Member | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
TPG Capital LP
 TPG Capital LP Financial ConglomeratesFinance TPG Capital LP provides financial investment services. The company was founded by David Bonderman, William S. Price III and James George Coulter Jr. and is headquartered in Houston, TX. | Financial Conglomerates | Corporate Officer/Principal | |
The Pfizer Foundation, Inc.
 The Pfizer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., The Pfizer Foundation, Inc. is a company committed to transparency and disclosure of activities of public interest. The company is based in New York, NY. Pfizer is dedicated to discovering breakthrough treatments, including medicines and vaccines, to benefit patients worldwide. The company is focused on treating 225 million people with these breakthrough treatments by 2025. The company's areas of interest include funding for educational activities, health education, and scientific research. Additionally, Pfizer is exploring the potential of mRNA technology to fight viruses and is working to understand the differences between biologics and biosimilars, particularly in terms of cost. | Miscellaneous Commercial Services | Director/Board Member | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Compliance Officer | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Chairman | |
XTuit Pharmaceuticals, Inc.
 XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
New York State Association of Realtors
 New York State Association of Realtors Miscellaneous Commercial ServicesCommercial Services The New York State Association of Realtors is a not-for-profit trade organization based in Albany, NY. It represents over 58,000 real estate professionals in the state and offers various benefits such as legislative and legal representation, educational programs, publications, and a code of professional standards. The association uses the term "realtor" as a registered trademark to identify real estate professionals who adhere to a strict code of ethics as members of the National Association of Realtors. These realtors are also members of the New York Association of Realtors and their local board or association of realtors. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Chairman | |
| QUESTCOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Compliance Officer | |
| San Francisco State University | College/University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 49 |
| Irlande | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 5 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 185 |
| Independent Dir/Board Member | 72 |
| Corporate Officer/Principal | 59 |
| Undergraduate Degree | 29 |
| Chairman | 25 |
Relations les plus connectées
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Carol Gallagher | 39 |
| Clarence Machado | 30 |
| Simeon George | 23 |
| Mark Alles | 20 |
| Jacob Chacko | 18 |
| Sheila Gujrathi | 18 |
| Barbara Bodem | 16 |
| Mohammad Hirmand | 14 |
| Garry Nicholson | 14 |
| Annette C. North | 11 |
| Raymond Furey | 11 |
| Adam Levy | 8 |
| Siegfried Reich | 8 |
| Brian Baker | 7 |
- Bourse
- Insiders
- Gavin Hirst
- Connexions Sociétés
